Wall Street is finally starting to buy ServiceNow CEO Bill McDermott’s story as the company beats Q2 earnings forecasts

ServiceNow’s Q2 subscription revenue rose 24.5% to $3.88B (total revenue +24% to just under $4B), beating the high end of its own guidance, and adjusted EPS of $0.90 beat the ~$0.86 Street estimate. The company raised full-year subscription-revenue guidance to $15.76B–$15.78B and lifted remaining performance obligations 21% to $13.2B (total RPO $29B, +21%). Shares rebounded sharply—down ~6.5% in-session before the print—then jumped as much as ~7% after-hours, suggesting investors are revisiting ServiceNow’s positioning as an “agentic AI” control layer.

Analysis

The market is pricing NOW less like a mature workflow vendor and more like a toll booth on enterprise AI governance. That matters because the first wave of agent spend is usually less about raw model usage and more about audit, identity, permissions, and orchestration—budget lines that expand when companies move from pilots to production. That makes NOW a relative winner versus pure model-layer narratives, while also creating second-order upside for security names such as PANW and CRWD as agent sprawl forces more controls.

Near term, the main risk is that some of the apparent strength is pull-forward from pricing changes and timing shifts rather than a clean acceleration in end-demand. If next quarter shows any deceleration in contracted backlog or AI attach, the stock can give back the re-rating quickly because the multiple already assumes sustained premium growth. The key horizon is 1-3 months for proof, while the 6-18 month question is whether NOW becomes the default control plane or remains a high-quality but expensive legacy SaaS asset.

Consensus is still underestimating that enterprise AI may monetize through governance, not generation. That said, the move may be partially overdone after the earnings squeeze, so chasing common stock into strength has worse risk/reward than a defined-risk structure. The thesis breaks if cRPO/RPO growth rolls over, if AI ACV stops compounding at a premium rate, or if management has to lean on price to defend growth.

Key Decisions for Investors

• Buy NOW on a 2-3 day post-earnings consolidation, not into the first squeeze; target 10-15% upside over 1-3 months if backlog and AI attach hold, and cut if the stock loses the post-gap level or next-quarter cRPO decelerates.
• Express the view with a defined-risk call spread in NOW rather than outright stock; the multiple is still rich, so the cleanest risk/reward is upside participation without paying full delta for a rerating that may take several quarters.
• Pair long NOW / short WDAY over the next 1-3 months to isolate the thesis that governance-centric workflow winners should outperform generic enterprise SaaS if agentic AI spend shifts toward control and compliance.
• Add a small long basket in PANW/CRWD as a second-order beneficiary over 3-6 months; rising agent sprawl should lift security budget intensity, but abandon the trade if billings or growth guidance do not inflect.
• Do not chase MSFT or PLTR here; wait for evidence that enterprise buyers are paying for the control layer rather than just the model layer, which would be the cleaner signal that this rerating is structural.